A global perspective on early and post-trial access, real-world data, and regulatory innovation
Insights from our flagship February 2025 event, now available in a five-part virtual series.
As the world leader in providing access to innovative medicines, we’re proud to present the virtual insights series — a high-impact series, drawing on the key insights and themes from our in-person event in Windsor, UK (February 2025).
Through five expert-led webinars, we explore the evolving access landscape across key markets and mechanisms — from post-trial access and early access schemes to real-world data and HTA readiness.
This is essential content for professionals in:
- Market access
- Regulatory affairs
- Real-world evidence
- Policy and advocacy
- Clinical operations
Each episode is 45–60 minutes and free to attend. Click through to register and view speaker details.
Explore the episodes
Episode 1: The phenomenal increase in post-trial access (PTA) An insight into future provision and the operational practicalities of PTA Date: Monday, 12 May 2025 at 3:00 PM BST | |
Episode 2: Real-world data: the French landscape and global impact How RWD is shaping decision-making in France – and influencing global practice Date: Tuesday, 13 May 2025 at 3:00 PM BST | |
Episode 3: UK early access to medicines scheme – 10 years on Reflecting on a decade of EAMS: evolution, impact, and future potential Date: Wednesday, 14 May 2025 at 3:00 PM BST | |
Episode 4: Can data from managed access support HTA evaluation? Using access program data to inform HTA decisions and accelerate uptake Date: Thursday, 15 May 2025 at 3:00 PM BST | |
Episode 5: How to operationalise the French early access system – the rules and the exceptions A practical guide to navigating France’s early access pathway Date: Friday, 16 May 2025 at 3:00 PM BST |